DOXORUBICIN HYDROCHLORIDE LIPOSOME
Alembic Pharmaceuticals gets USFDA nod for generic cancer treatment injectionAlembic Pharmaceuticals has received final USFDA approval. This approval is for its generic Doxorubicin Hydrochloride Liposome injection. T...
Alembic Pharma shares rally 12% on USFDA nod for cancer drugAlembic Pharmaceuticals surged 12% to Rs 1,089.80 after securing USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injectio...
Lupin launches generic cancer drug in USLupin has launched a generic cancer treatment drug, Doxorubicin Hydrochloride Liposome Injection, in the US market. The product is a generi...
- Load More